Home Data Calendar Blog

ALNY

Tables

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Common Stock Value 1.291.291.281.261.261.251.251.241.241.231.211.211.201.201.191.171.161.161.161.131.121.111.111.061.011.011.001.00NA1.000.920.920.86
Weighted Average Number Of Diluted Shares Outstanding NA128.59126.73126.14NA131.34124.66124.11NA122.17120.90120.39NA119.14117.77117.08NA115.99114.91NANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic NA128.59126.73126.14NA125.22124.66124.11NA122.17120.90120.39NA119.14117.77117.08NA115.99114.91NANANANANANANANANANANANANANA
Earnings Per Share Basic -0.65-0.87-0.13-0.52-1.091.18-2.21-1.40-1.68-3.32-2.29-2.00-2.16-1.72-1.61-1.71-2.09-2.18-1.56NANANANANANANANANANANANANANA
Earnings Per Share Diluted -0.65-0.87-0.13-0.52-1.091.15-2.21-1.40-1.68-3.32-2.29-2.00-2.16-1.72-1.61-1.71-2.09-2.18-1.56NANANANANANANANANANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax 593.17500.92659.83494.33439.72750.53318.75319.29335.04264.31224.82213.26258.54187.63220.55177.57163.56125.85103.9699.4871.6870.0644.7133.2921.032.0729.9121.902.9037.9217.1015.9318.96
Revenues 593.17500.92659.83494.33439.72750.53318.75319.29335.04264.31224.82213.26258.54187.63220.55177.57163.56125.85103.9699.4871.6870.0644.7133.2921.032.0729.9121.902.9037.9217.1015.9318.96
Cost Of Goods And Services Sold 102.6581.9867.2754.6171.9779.4775.3441.4346.1736.5134.0423.4633.6328.0930.2623.0223.0221.8019.9313.3012.185.214.333.351.670.14NANANANANANANA
Costs And Expenses 698.33577.82611.21537.77556.12536.66548.59469.10523.65522.35416.50359.99453.10369.31366.71363.82357.78351.05302.82309.63369.75286.36280.99222.08241.39256.63222.26169.30NA185.23142.90136.41125.47
Research And Development Expense 300.17270.93294.14261.00272.14253.18248.53230.57262.04245.37205.71169.89229.05194.57182.63185.90168.47161.78155.00169.57201.30160.80163.89129.13131.04139.94137.5896.86NA117.7795.2590.6386.98
Selling General And Administrative Expense 295.34220.99248.40210.80198.12199.18214.69183.66210.34235.86169.98154.47186.38142.07145.32146.86166.29167.47127.90126.76156.28120.35112.7789.61108.69116.5584.6872.45NA67.4547.64NANA
Operating Income Loss -105.16-76.9148.61-43.44-116.40213.87-229.83-149.81-188.61-258.04-191.69-146.73-194.56-181.68-146.16-186.25-194.22-225.20-198.86-210.16-298.07-216.30-236.27-188.79-220.36-254.56-192.35-147.41NA-147.30-125.80-120.47-106.51
Interest Paid Net 12.3316.158.1630.955.449.553.2213.911.3014.8714.9414.126.959.35NANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 91.6445.8089.2945.3541.9963.9475.8039.9542.77128.1230.4729.2944.5833.3732.0855.6934.2837.2633.7634.5866.2046.0130.6032.0327.9787.9522.2419.58NANANANANA
Income Tax Expense Benefit -110.192.915.722.350.182.991.811.740.47-0.022.730.98-1.840.281.231.02-0.060.841.330.57-0.40-0.390.960.690.360.450.08-0.06NANANANANA
Other Comprehensive Income Loss Net Of Tax -9.699.81-7.65-3.618.964.742.045.53-0.87-1.56-4.16-4.810.971.850.646.91-6.43-3.98-1.154.46-2.151.46-2.980.360.180.411.05-0.42NANANANANA
Net Income Loss -83.76-111.57-16.89-65.94-137.87147.75-276.02-174.10-207.49-405.92-277.40-240.34-258.46-204.51-189.56-200.29-243.54-253.29-179.23-182.22-276.19-208.53-219.48-181.91-211.44-245.28-163.56-141.21NA-142.23-122.94-118.42-107.29
Comprehensive Income Net Of Tax -93.45-101.76-24.54-69.55-128.91152.49-273.98-168.57-208.36-407.48-281.56-245.15-257.49-202.66-188.92-193.39-249.97-257.27-180.38-177.76-278.33-207.07-222.46-181.56-211.26-244.87-162.51-141.63NA-142.92-122.72-118.55-107.68

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets 4239.984205.044009.633824.393829.883839.073402.403391.943546.363535.263330.423433.553643.303472.313509.433255.273407.063307.283374.372279.622395.132541.622716.412014.001574.801675.651789.391923.14NA1994.731358.281434.281133.93
Liabilities 4172.904172.694012.704043.664050.524004.943810.533651.183704.583602.893154.383032.383055.102716.422656.072329.082390.812092.261974.64929.89956.44934.53959.22467.01272.84197.53168.59168.33NA228.30299.45311.32303.02
Liabilities And Stockholders Equity 4239.984205.044009.633824.393829.883839.073402.403391.943546.363535.263330.423433.553643.303472.313509.433255.273407.063307.283374.372279.622395.132541.622716.412014.001574.801675.651789.391923.14NA1994.731358.281434.281133.93
Stockholders Equity 67.0932.35-3.07-219.27-220.64-165.87-408.13-259.24-158.22-67.64176.04401.17588.20755.89853.36926.191016.251215.021399.731349.731438.691607.091757.191546.991301.961478.121620.801754.81NA1766.431058.841122.97830.90

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets Current 3295.283355.423172.862988.612982.702985.452524.052541.022692.252690.852471.642589.682808.582675.362725.162470.082614.782554.702160.451584.771715.861897.272063.771392.011200.701342.121502.561685.30NA1764.74993.37960.71597.19
Cash And Cash Equivalents At Carrying Value 966.431099.92968.49681.88812.691033.02657.80672.25866.391073.23575.56534.08819.981093.99745.77379.54496.58496.70580.83467.78547.18923.301136.29724.96420.15316.61361.46396.15NA645.36202.04408.67171.08
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 968.651102.50971.19684.72814.881035.21659.98674.41868.561075.39577.74536.26822.151096.46748.07NA499.05NANANANANANANANANANA397.88NA646.83NANA172.55
Accounts Receivable Net Current 405.31353.85309.48321.38327.79325.44220.63219.43237.96184.51142.27156.53198.57141.06146.59110.63102.4179.1269.1175.5743.0148.1130.7433.8018.763.36NANANA34.00NANANA
Inventory Net 78.5175.9983.9893.9989.1595.77100.45131.88128.96115.4988.9878.5286.3697.9084.3673.9475.2066.9477.4268.3056.3554.5640.5932.0024.07NANANANANANANANA
Inventory Finished Goods 26.4323.1327.8624.8225.1227.6628.5029.5325.6121.4813.1910.437.0012.6716.4513.7512.697.2613.224.232.650.580.450.140.10NANANANANANANANA
Prepaid Expense And Other Assets Current 116.96145.35154.75201.96126.38157.96145.45119.03132.92125.52129.78115.0688.08108.5394.1475.9862.7774.7788.3598.7080.3473.5465.6281.6773.7190.8451.9366.67NA40.1230.4322.0318.13
Equity Securities Fv Ni 8.168.329.8911.2611.1810.4127.2625.8628.1223.0530.9032.0066.9772.5552.5356.9744.6357.2286.3138.0813.97NANANA1.2115.0012.04NANANANANANA
Available For Sale Securities Debt Securities 1789.011681.181688.881734.911649.671380.951380.381376.761411.131238.131593.731727.451603.621171.321101.781273.031353.181294.951268.42972.841315.151471.901589.331049.81662.80905.221074.161172.36NA1059.18797.79689.17641.15

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Property Plant And Equipment Gross 773.15NANANA749.13NANANA696.94NANANA642.37NANANA569.38NANANA501.34NANANA400.14NANANANA249.25NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 270.36NANANA223.08NANANA173.45NANANA140.41NANANA104.35NANANA76.16NANANA79.48NANANANA67.35NANANA
Property Plant And Equipment Net 502.78507.00517.16523.46526.06525.59527.47523.03523.49514.82508.20504.39501.96484.94470.70464.57465.03444.69439.13429.81425.18396.46371.77341.71320.66272.65227.84201.98NA181.90161.90147.53129.96
Other Assets Noncurrent 65.3177.6271.9267.4672.0075.1692.6963.4566.0961.4077.2769.8260.2035.2734.5942.6845.0537.9320.4019.0318.079.639.699.048.6216.0614.175.21NA4.171.471.471.47
Equity Securities Fv Ni 8.168.329.8911.2611.1810.4127.2625.8628.1223.0530.9032.0066.9772.5552.5356.9744.6357.2286.3138.0813.97NANANA1.2115.0012.04NANANANANANA
Available For Sale Debt Securities Amortized Cost Basis 1787.461674.851691.631736.931648.131386.441387.751382.111420.601250.761604.311736.301605.241171.291101.681272.681352.831294.051266.04968.661315.011471.551588.921049.87663.22905.821075.181174.42NA1060.82798.74690.34642.18

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Liabilities Current 1186.271220.661055.25941.71967.79949.78788.64673.39767.91772.79657.68605.96695.71610.66554.65494.82585.27480.24384.30338.79352.59352.86328.60149.16179.49121.50113.66115.38NA144.25101.05108.7395.79
Accounts Payable Current 88.4270.8173.9878.1555.5273.8459.7562.2498.0940.5752.4254.9273.4340.0553.0845.3851.9727.8726.1240.4849.8839.3971.2222.6759.7121.7711.9913.21NA28.369.2423.1725.37
Other Accrued Liabilities Current 123.16NANANA53.96NANANA59.54NANANA46.15NANANA49.59NANANA27.09NANANA23.63NANANANA10.86NANANA
Accrued Liabilities Current 887.47946.17808.64698.87713.01713.09598.53508.60545.46510.58421.24355.94395.17388.58341.19280.53355.91295.26211.19183.22197.20177.95138.80106.87112.7293.5689.8763.82NA72.2051.2643.8231.84
Contract With Customer Liability Current 55.4871.0369.0176.85102.7577.1454.6435.7942.10144.21114.29131.84149.48115.0498.14116.34127.21114.60107.5986.0477.82107.3689.242.643.503.449.16NANA41.70NANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Other Liabilities Noncurrent 398.11357.48350.43319.99308.44280.73257.05224.05212.58183.00157.30120.8398.9676.4571.6360.4637.9116.3418.869.209.339.049.515.074.964.334.194.46NA4.352.842.813.18
Operating Lease Liability Noncurrent 229.54236.03239.35237.83243.10247.71253.42259.40261.34266.32272.02277.39281.35286.03288.56288.01293.04297.26281.62275.78276.13276.46277.21NANANANANANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Stockholders Equity 67.0932.35-3.07-219.27-220.64-165.87-408.13-259.24-158.22-67.64176.04401.17588.20755.89853.36926.191016.251215.021399.731349.731438.691607.091757.191546.991301.961478.121620.801754.81NA1766.431058.841122.97830.90
Common Stock Value 1.291.291.281.261.261.251.251.241.241.231.211.211.201.201.191.171.161.161.161.131.121.111.111.061.011.011.001.00NA1.000.920.920.86
Additional Paid In Capital Common Stock 7388.067259.887122.706881.986811.066736.946647.176522.096454.546336.776172.996116.566058.455968.665863.485747.395644.075592.885520.325289.975201.185091.255034.284601.664175.144140.034037.854009.34NA3947.553097.113038.532627.97
Retained Earnings Accumulated Deficit -7287.75-7203.98-7092.41-7075.53-7009.59-6871.72-7019.47-6743.45-6569.35-6361.86-5955.94-5678.53-5438.19-5179.73-4975.22-4785.66-4585.37-4341.83-4088.54-3909.31-3727.09-3450.90-3242.37-3022.89-2840.97-2629.53-2384.25-2220.69NA-2147.68-2005.46-1882.52-1764.10
Accumulated Other Comprehensive Income Loss Net Of Tax -34.52-24.83-34.64-26.99-23.38-32.34-37.08-39.12-44.65-43.78-42.22-38.06-33.26-34.23-36.08-36.72-43.62-37.19-33.21-32.06-36.52-34.37-35.83-32.85-33.21-33.39-33.81-34.85NA-34.43-33.74-33.96-33.83
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA46.6190.1046.16NA64.8776.9941.14NA129.1334.4530.05NA33.7032.9356.30NA40.2333.7134.58NA46.6630.8032.54NA88.4122.0019.46NANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities -94.6643.71124.16-81.52-29.80359.41-58.99-166.47-131.98-115.28-122.82-171.19-150.14-134.04-121.86-235.66-123.14-110.33-135.33-246.16-195.98-182.63288.69-188.51-150.46-153.81-102.69-155.66NA-103.04-98.36NANA
Net Cash Provided By Used In Investing Activities -52.91-30.2533.94-67.62-240.66-10.76-8.71-76.22-139.91313.89142.79-147.42-413.40-88.27157.0271.35-97.89-10.09-441.23113.69-220.85-10.08-289.40102.65248.9696.1762.62-134.81NA-160.59-137.18NANA
Net Cash Provided By Used In Financing Activities 31.00102.75131.5028.9139.2333.1453.3946.3763.44297.0230.3434.96292.29573.84329.8151.18217.9534.15689.0153.8740.34-20.70412.61390.935.3812.995.5841.52NA706.9528.91NANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities -94.6643.71124.16-81.52-29.80359.41-58.99-166.47-131.98-115.28-122.82-171.19-150.14-134.04-121.86-235.66-123.14-110.33-135.33-246.16-195.98-182.63288.69-188.51-150.46-153.81-102.69-155.66NA-103.04-98.36NANA
Net Income Loss -83.76-111.57-16.89-65.94-137.87147.75-276.02-174.10-207.49-405.92-277.40-240.34-258.46-204.51-189.56-200.29-243.54-253.29-179.23-182.22-276.19-208.53-219.48-181.91-211.44-245.28-163.56-141.21NA-142.23-122.94-118.42-107.29
Increase Decrease In Accounts Receivable 59.5137.09-9.64-0.41-3.87107.992.97-19.1553.2738.42-6.40-39.7059.45-3.6735.3110.7121.178.97-6.7832.88-5.4817.78-3.1115.0415.400.40-47.8116.77NA19.36NANANA
Increase Decrease In Inventories -0.85-5.92-6.79-0.02-11.99-4.79-1.990.4018.987.889.20-1.9310.7613.633.96-1.938.462.7812.2311.954.3213.057.917.1312.29NANANANANANANANA
Share Based Compensation 91.6445.8089.2945.3541.9963.9475.8039.9542.77128.1230.4729.2944.5833.3732.0855.6934.2837.2633.7634.5866.2046.0130.6032.0327.9787.9522.2419.58NA27.1225.9524.0315.72

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Investing Activities -52.91-30.2533.94-67.62-240.66-10.76-8.71-76.22-139.91313.89142.79-147.42-413.40-88.27157.0271.35-97.89-10.09-441.23113.69-220.85-10.08-289.40102.65248.9696.1762.62-134.81NA-160.59-137.18NANA
Payments To Acquire Property Plant And Equipment 9.094.198.0212.9715.3117.0915.9213.8921.6416.5116.0517.8621.8926.0611.2517.1821.6712.4216.6619.6238.8036.0621.2444.0537.5145.4122.7121.26NA20.7325.6821.6536.15

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Financing Activities 31.00102.75131.5028.9139.2333.1453.3946.3763.44297.0230.3434.96292.29573.84329.8151.18217.9534.15689.0153.8740.34-20.70412.61390.935.3812.995.5841.52NA706.9528.91NANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-01-01 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenues 593.17500.92659.83494.33439.72750.53318.75319.29335.04264.31224.82213.26258.54187.63220.55177.57163.56125.85103.9699.4871.6870.0644.7133.2921.032.0729.9121.902.9037.9217.1015.9318.96
Revenue From Contract With Customer Excluding Assessed Tax 593.17500.92659.83494.33439.72750.53318.75319.29335.04264.31224.82213.26258.54187.63220.55177.57163.56125.85103.9699.4871.6870.0644.7133.2921.032.0729.9121.902.9037.9217.1015.9318.96
Regeneron Pharmaceuticals Incorporation, C5 License Obligation, Global Strategic Collaboration 19.448.408.801.70-21.100.703.102.2034.601.40-4.801.3014.201.2015.7013.50NANA0.00NANANANANANANANANANANANANANA
Regeneron Pharmaceuticals Incorporation, Research Services Obligation, Global Strategic Collaboration 9.3011.104.0014.7013.5073.00-17.0010.709.5010.301.607.208.708.9010.209.8011.5010.7010.3012.309.2011.10NANANANANANANANANANANA
Roche, Development Services Obligation, Roche Collaboration And License Agreement 10.9214.8812.807.1523.770.20NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Roche, License Obligation, Roche Collaboration And License Agreement 0.000.000.0065.000.00310.00NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Novartis, Collaborative Arrangement NA2.942.3014.52NA18.388.6314.93NA5.808.5313.14NA4.168.918.11NA1.093.881.06NANANANANANANANANANANANANA
Other Collaborations, Collaborative Arrangement 4.270.211.102.592.0917.510.051.54-0.241.510.480.400.500.580.100.520.141.750.320.460.060.460.310.210.030.210.060.51NA3.010.24NANA
Regeneron Pharmaceuticals Incorporation, Global Strategic Collaboration 28.7419.5012.8017.10-6.4075.70-12.2015.4054.7817.10-1.5010.8025.4012.6037.3025.8020.8013.1013.2016.508.5014.70NANANANANANANANANANANA
Regeneron Pharmaceuticals Incorporation, Collaborative Arrangement 30.6637.95207.4326.763.0680.25-2.8419.9953.4421.980.0112.4122.3214.1646.4030.3424.2814.8715.4119.5010.1115.260.700.000.000.00NANANANANANANA
Roche, Roche Collaboration And License Agreement 10.9214.8812.8072.1523.77310.20NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Roche, Collaborative Arrangement NA16.2916.5174.68NA311.33NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Amvuttra 286.51258.59230.11195.24175.25148.68132.14101.7768.5725.23NANANANANANANANANANANANANANANANANANANANANANANA
Collaborations 106.9557.39227.34118.5576.41427.475.8436.4670.6429.309.0325.95NANANANANANANANANANANANANANANANANANANANANA
GIVLAARI 64.6471.0462.1358.0659.3054.1557.9047.9147.0645.6645.1535.2840.6831.8330.6324.6722.1416.6911.005.27NANA0.000.00NANANANANANANANANA
ONPATTRO 56.1050.2977.2469.2279.0181.5991.46102.49122.22144.95153.43137.01138.63120.32113.84101.9590.3782.5266.5366.6655.8046.0738.2326.29NANANANANANANANANA
OXLUMO 43.5740.2240.6142.6532.7328.7424.2124.1623.8316.4314.9414.5919.2014.8916.349.14NANANANANANANANANANANANANANANANANA
Product 450.83420.15410.09365.16346.29313.15305.70276.33261.68232.27213.51186.87198.51167.04160.81135.77112.8499.2177.5371.9455.9546.0738.2326.2912.070.46NA0.00NANANANANA
Royalty 35.3923.3922.4010.6217.029.907.216.502.712.742.280.440.400.450.35NANANANANANANANANANANANANANANANANANA
Amvuttra, 69.8165.1456.7643.7330.3119.4214.406.774.040.17NANANANANANANANANANANANANANANANANANANANANANANA
Amvuttra,US 183.25168.66148.46130.24122.18113.5196.4779.0157.4625.06NANANANANANANANANANANANANANANANANANANANANANANA
Amvuttra, Non U S Or Europe 33.4524.7924.8921.2722.7715.7621.2615.99NANANANANANANANANANANANANANANANANANANANANANANANANA
GIVLAARI, 18.0016.2816.3115.3116.5512.4314.0514.4712.6112.4813.899.698.437.578.026.875.084.582.34NANANANANANANANANANANANANANA
GIVLAARI,US 45.0540.3741.2338.7339.4637.0135.2030.2931.1531.1729.6623.6830.2522.3722.3717.7616.7512.118.665.27NANANANANANANANANANANANANA
GIVLAARI, Non U S Or Europe 1.6014.394.594.013.294.718.653.143.292.011.591.912.001.890.240.04NANANANANANANANANANANANANANANANANA
ONPATTRO, 28.1124.3337.0744.6944.4750.3756.3959.6856.8857.2256.7953.1853.8651.0244.9040.6533.0930.4823.0221.1715.6710.86NANANANANANANANANANANA
ONPATTRO,US 19.9316.2122.1116.5420.4921.8725.5629.8246.1667.2071.0862.3160.1051.2552.3949.4743.0839.0332.2737.2035.7633.59NANANANANANANANANANANA
ONPATTRO, Non U S Or Europe 8.079.7618.067.9914.049.359.5113.0019.1820.5425.5621.5224.6718.0516.5411.8314.1913.0111.258.304.371.62NANANANANANANANANANANA
OXLUMO, 18.8519.9820.5021.4319.4115.0912.2213.3112.829.357.598.1611.729.669.837.74NANANANANANANANANANANANANANANANANA
OXLUMO,US 18.7614.9315.7413.3310.609.718.799.068.786.387.125.415.725.246.511.41NANANANANANANANANANANANANANANANANA
OXLUMO, Non U S Or Europe 5.975.314.367.892.723.943.201.792.230.700.221.02NANANANANANANANANANANANANANANANANANANANANA
Collaborative Arrangement 106.9557.39227.34118.5576.41427.475.8436.4670.6429.309.0325.9559.6220.1459.4041.8050.7226.6526.4327.5415.7324.006.487.008.961.6129.9121.90NA37.9217.1015.93NA

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Expenses
Income Tax Expense Benefit
Balance Sheet
Stockholders Equity
Assets
Equity Securities Fv Ni
Current Assets
Inventory Net
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Year Four
InventoryNet
Inventory Finished Goods

Line plots across dimensions of each concept